Experimental Hematology & Oncology | Most Viewed

Submit a manuscript Register Contact us Follow
BioMed Central Support

Explore journal

Advertisement

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 509 Accesses	Case report Hyperphosphatemia during spontaneous tumor lysis syndrome culminate in severe hypophosphatemia at the time of blast crisis of Ph^neg CML to acute myelomoncytic leukemia Ophira Salomon, Eli J Holtzman, Pazit Beckerman, Camila Avivi, Luba Trakhtenbrot, Abraham Kneller, Tali Tohami, Yeroham Kleinbaum, Sara Apter, Ninette Amariglio, Ehud Grossman, Ginette Schiby Experimental Hematology & Oncology 2012, 1:24 (29 August 2012) Abstract \| Full text \| PDF \| PubMed
	2. 318 Accesses	Review CD19: a biomarker for B cell development, lymphoma diagnosis and therapy Kemeng Wang, Guoqing Wei, Delong Liu Experimental Hematology & Oncology 2012, 1:36 (29 November 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	3. 275 Accesses	Review Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC) Liping Dai, Ningjing Lei, Mei Liu, Jian-Ying Zhang Experimental Hematology & Oncology 2013, 2:15 (20 May 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	4. 209 Accesses	Review Thalidomide and its analogues in the treatment of Multiple Myeloma Tahir Latif, Nabeel Chauhan, Rashid Khan, Andrea Moran, Saad Z Usmani Experimental Hematology & Oncology 2012, 1:27 (11 September 2012) Abstract \| Full text \| PDF \| PubMed
	5. 199 Accesses	Review Digitoxin and its analogs as novel cancer therapeutics Hosam A Elbaz, Todd A Stueckle, William Tse, Yon Rojanasakul, Cerasela Dinu Experimental Hematology & Oncology 2012, 1:4 (5 April 2012) Abstract \| Full text \| PDF \| Editor’s summary Elbaz et al assess the cytotoxicity of digitoxin and its analogs against cancer cells, and present a new perspective on the pharmacological aspects of digitoxin for developing potent chemotherapeutic drugs.
	6. 191 Accesses	Research The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis Stuart Mealing, Leticia Barcena, Neil Hawkins, James Clark, Victoria Eaton, Ishan Hirji, Catherine Davis Experimental Hematology & Oncology 2013, 2:5 (19 February 2013) Abstract \| Full text \| PDF \| PubMed
	7. 191 Accesses	Research Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma Efstathios Koulieris, Panayiotis Panayiotidis, Stephen J Harding, Nikolitsa Kafasi, Dimitris Maltezas, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, George Georgiou, Ladan Mirbahai, Arthur R Bradwell, Marie-Christine Kyrtsonis Experimental Hematology & Oncology 2012, 1:9 (23 April 2012) Abstract \| Full text \| PDF
	8. 182 Accesses	Case report Donor Vδ1⁺ γδ T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL Immo Prinz, Kristina Thamm, Matthias Port, Eva M Weissinger, Michael Stadler, Ildar Gabaev, Roland Jacobs, Arnold Ganser, Christian Koenecke Experimental Hematology & Oncology 2013, 2:14 (11 May 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	9. 173 Accesses	Case report Cardiac metastasis from yolk sac tumor: case report and review Maria Carmo Pereira Nunes, Daniel Moreira, Teresa Cristina Abreu Ferrari Experimental Hematology & Oncology 2013, 2:13 (30 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	10. 173 Accesses	Case report “T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach” Carlos A Tirado, Phillip Starshak, Paul Delgado, Nagesh Rao Experimental Hematology & Oncology 2012, 1:21 (20 August 2012) Abstract \| Full text \| PDF \| PubMed
	11. 175 Accesses	Research Targeting early B-cell receptor signaling induces apoptosis in leukemic mantle cell lymphoma Mohand-Akli Boukhiar, Claudine Roger, Julie Tran, Remy Gressin, Antoine Martin, Florence Ajchenbaum-Cymbalista, Nadine Varin-Blank, Dominique Ledoux, Fanny Baran-Marszak Experimental Hematology & Oncology 2013, 2:4 (19 February 2013) Abstract \| Full text \| PDF \| PubMed
	12. 143 Accesses	Short report Pattern of antigen expression in metastases after radioimmunotherapy of a syngeneic rat colon carcinoma utilizing the BR96 antibody Erika Elgström, Sophie E Eriksson, Tomas G Ohlsson, Jan Tennvall, Rune Nilsson Experimental Hematology & Oncology 2012, 1:34 (13 November 2012) Abstract \| Full text \| PDF \| PubMed
	13. 141 Accesses	Methodology Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety Yue Ma, Ying-Chun Xu, Lei Tang, Zan Zhang, Jian Wang, Hong-Xia Wang Experimental Hematology & Oncology 2012, 1:11 (26 April 2012) Abstract \| Full text \| PDF
	14. 130 Accesses	Research Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors Sue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, Denise Niewerth, Johan van Meerloo, Jacqueline Cloos, Michael van der Veer, George L Scheffer, Godefridus J Peters, Elena T Chan, Janet L Anderl, Christopher J Kirk, Sonja Zweegman, Ben AC Dijkmans, Willem F Lems, Rik J Scheper, Tanja D de Gruijl, Gerrit Jansen Experimental Hematology & Oncology 2013, 2:2 (10 January 2013) Abstract \| Full text \| PDF \| PubMed
	15. 128 Accesses	Review Polo-like kinase 1 as target for cancer therapy Lily Weiß, Thomas Efferth Experimental Hematology & Oncology 2012, 1:38 (10 December 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	16. 127 Accesses	Research In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines Ping Wang, Zhenhe Suo, Mengyu Wang, Hanne K Høifødt, Øystein Fodstad, Gustav Gaudernack, Gunnar Kvalheim Experimental Hematology & Oncology 2013, 2:16 (6 June 2013) Abstract \| Provisional PDF \| PubMed
	17. 125 Accesses	Review Expansion of hematopoietic stem cells for transplantation: current perspectives Jessica A Schuster, Maria R Stupnikov, Gina Ma, Wenbin Liao, Raymond Lai, Yupo Ma, Jerell R Aguila Experimental Hematology & Oncology 2012, 1:12 (14 May 2012) Abstract \| Full text \| PDF
	18. 122 Accesses	Review Current management and prognostic features for gastrointestinal stromal tumor (GIST) Gurpreet Lamba, Ridhi Gupta, Byung Lee, Samir Ambrale, Delong Liu Experimental Hematology & Oncology 2012, 1:14 (18 June 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	19. 122 Accesses	Review Three are better than one: plasminogen receptors as cancer theranostic targets Patrizia Ceruti, Moitza Principe, Michela Capello, Paola Cappello, Francesco Novelli Experimental Hematology & Oncology 2013, 2:12 (17 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	20. 117 Accesses	Short report R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma Yuko Mishima, Yasuhito Terui, Masahiro Yokoyama, Noriko Nishimura, Sakura Sakajiri, Kyoko Ueda, Yasutoshi Kuboki, Kenji Nakano, Kazuhito Suzuki, Eriko Nara, Naoko Tsuyama, Kengo Takeuchi, Masahiko Oguchi, Kiyohiko Hatake Experimental Hematology & Oncology 2012, 1:30 (24 September 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	21. 113 Accesses	Research Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia Hamilton L Gimenes-Teixeira, Antonio R Lucena-Araujo, Guilherme A dos Santos, Dalila L Zanette, Priscila S Scheucher, Luciana C Oliveira, Leandro F Dalmazzo, Wilson A Silva-Júnior, Roberto P Falcão, Eduardo M Rego Experimental Hematology & Oncology 2013, 2:10 (8 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	22. 113 Accesses	Research French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia Pascale Trioche, Brigitte Nelken, Gérard Michel, Isabelle Pellier, Arnaud Petit, Yves Bertrand, Pierre Rohrlich, Claudine Schmitt, Nicolas Sirvent, Patrick Boutard, Geneviève Margueritte, Brigitte Pautard, Stéphane Ducassou, Dominique Plantaz, Alain Robert, Caroline Thomas, Kristell Desseaux, Sylvie Chevret, André Baruchel Experimental Hematology & Oncology 2012, 1:39 (10 December 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	23. 110 Accesses	Research Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis Shamudheen M Rafiyath, Mohammad Rasul, Byung Lee, Guoqing Wei, Gurpreet Lamba, Delong Liu Experimental Hematology & Oncology 2012, 1:10 (23 April 2012) Abstract \| Full text \| PDF
	24. 106 Accesses	Research Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment Fung Kwong-Lam, Chan Godfrey Chi-Fung Experimental Hematology & Oncology 2013, 2:11 (10 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	25. 103 Accesses	Review The forgotten tale of immunoglobulin allotypes in cancer risk and treatment Janardan P Pandey, Zihai Li Experimental Hematology & Oncology 2013, 2:6 (20 February 2013) Abstract \| Full text \| PDF \| PubMed